PR Newswire

ROCKVILLE, Md. and SHENZHEN, China, Oct. 27, 2023 /PRNewswire/ — HighTide Therapeutics, Inc. (“HighTide”), a globally integrated biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for metabolic and digestive diseases, announces that the company’s founder and CEO, Dr.

MIAMI, Oct. 26, 2023 /PRNewswire/ — Crystal Lagoons  has completed a major expansion in Australia. The multinational innovation company has signed an important contract with investment fund Vibranium Capital Partners to develop 16 new Public Access Lagoons™ projects, also known